101 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
6 May 24
Entry into a Material Definitive Agreement
7:31am
that PH-ILD affects approximately 60,000-100,000 patients in the US. Patients with PH-ILD in the US have access to only one approved therapy, while
8-K
EX-3.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
) days prior to the meeting: (a) on a reasonably accessible electronic network, provided that the information required to gain access to such list
8-K
EX-10.1
gogj rx7i34ukdh5
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
PRE 14A
7x5vtef 9251gwkb8hnh
17 Apr 23
Preliminary proxy
4:01pm
8-K
EX-99.1
kuciw8
3 Nov 22
Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update
4:00pm
8-K
EX-99.1
1xhpu2oi
9 Aug 22
Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update
8:08am
8-K
EX-10.1
hsatf
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
8-K
EX-99.1
inniv
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
8-K
EX-99.1
ag33 py3to
10 May 22
Gossamer Bio Announces First Quarter 2022 Financial Results and Provides Business Update
4:04pm